ClinConnect ClinConnect Logo
Search / Trial NCT06882525

Subcutaneous Lidocaine Injection in Acute Herpes Zoster Neuralgia and Post-herpetic Neuralgia

Launched by ANKARA CITY HOSPITAL BILKENT · Mar 17, 2025

Trial Information

Current as of April 23, 2025

Not yet recruiting

Keywords

Neuralgia, Postherpetic Herpes Zoster Lidocaine

ClinConnect Summary

Herpes zoster (HZ; shingles) is a disease associated with inflammation of peripheral nerves, which can progress with acute and chronic pain, and is considered a significant cause of postherpetic neuralgia (PHN). The varicella-zoster virus (VZV) causes a primary infection known as chickenpox. The virus then migrates to spinal and cranial sensory ganglia, becoming latent through nerve axons and possibly via viremia from the skin lesions. In some individuals later in life, the virus reactivates, causing a secondary infection known as HZ. When the virus reactivates, it progresses along the affe...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • patients over the age of 18
  • with acute HZ pain (rash duration \< 30 days
  • pain due to PHN (rash duration \> 3 months),
  • Exclusion Criteria:
  • patients on anticoagulants or have coagulation disorders, patients with psychomotor disorders patients with uncontrolled diabetes patients with bacterial infection or infectious discharge in the affected dermatomal region patients allergic to lidocaine patients with lesions in the facial or genital regions pregnant or breastfeeding patients

About Ankara City Hospital Bilkent

Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.

Locations

Ankara, Cankaya, Turkey

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported